- Home
- Services
- About Us
- Specials
- Pricing
- Locations
- Blog
- Contact Us
Our Mesa Eastmark office is a nurse practitioner-led medical wellness clinic serving the Eastmark community and surrounding areas of southeast Mesa. The office is located on Point Twenty-Two Boulevard near the Great Park, with convenient access from Loop 202 for patients traveling from Queen Creek, Apache Junction, Gold Canyon, and nearby communities.
Available services include medical weight management, hormone and testosterone therapy, IV therapy, ketamine infusion therapy, peptide consultations, and regenerative therapy. Services require an individualized clinical evaluation, and treatment eligibility varies by patient. Laboratory testing may be ordered when clinically appropriate.
Chad Dance, FNP-C, MSN, MS, serves as the clinician leading Keystone’s programs and works alongside the other licensed nurse practitioners at our locations. His background includes more than five years as an ICU nurse at a Level II trauma center. That experience contributes to the practice’s emphasis on careful evaluation, patient education, medication management, and appropriate follow-up.
Below, you can learn more about our available services, the communities we serve, and how to schedule an appointment. Call (480) 485-9677 or request an appointment online.
Our Mesa Eastmark office serves adults across a wide range of ages, health backgrounds, and treatment goals. This includes residents of Eastmark, Sunland Springs, and other nearby communities.
Each patient’s needs are different. Age, medical conditions, current medications, previous treatments, personal goals, and potential risk factors can all influence whether treatment is appropriate and how a care plan is developed. Medication selection, dosage, and monitoring are determined through an individualized clinical evaluation. Not every patient is a candidate for every treatment.
We welcome patients from Mesa, Queen Creek, Apache Junction, Gold Canyon, and surrounding communities. Our Point Twenty-Two Boulevard location offers convenient access and on-site parking for patients throughout the southeast Valley.
Medical weight management may be an option for adults who have had difficulty achieving or maintaining their goals through lifestyle changes alone. Our providers offer straightforward guidance about available options, realistic expectations, potential risks, and the ongoing commitment involved.
Depending on the medication and its approved indication, treatment may be considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, prediabetes, or sleep apnea. BMI is only one part of determining eligibility. Your provider will also review your health history, current medications, previous treatments, and individual risk factors before recommending a plan.
Not every patient is a candidate for prescription weight-management medication. A consultation is required, and treatment is not guaranteed.
We have multiple medication options at our Mesa Eastmark office, and they are the same as our Gilbert location. The selection process is highly individualized.
Semaglutide is a GLP-1 receptor agonist that supports appetite regulation, glucose management, and slower gastric emptying. FDA-approved medications containing Semaglutide include Wegovy, which is approved for chronic weight management in certain patients, and Ozempic, which has different approved uses.
Depending on a patient’s individual needs, a provider may discuss compounded Semaglutide as a treatment option. The medication is prepared by an FDA-registered 503A or 503B outsourcing facility operating under applicable federal manufacturing and compounding requirements. FDA registration of the facility does not mean that the compounded medication itself is FDA-approved.
Possible side effects include nausea, vomiting, diarrhea, abdominal discomfort, and constipation. Semaglutide may not be appropriate for patients with certain medical conditions, including a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
Your provider will review your medical history, current medications, treatment goals, and potential risks before determining whether Semaglutide may be appropriate. Individual experiences and results vary.
Tirzepatide acts on both GIP and GLP-1 receptors involved in appetite, glucose regulation, and digestion. FDA-approved medications containing Tirzepatide include Zepbound, which is approved for chronic weight management in certain eligible patients, and Mounjaro, which has different approved uses.
Depending on a patient’s individual needs, a provider may discuss compounded Tirzepatide as a treatment option. The medication is prepared by an FDA-registered 503A or 503B outsourcing facility operating under applicable federal manufacturing and compounding requirements. FDA registration of the facility does not mean that the compounded medication itself is FDA-approved.
Possible side effects include nausea, vomiting, diarrhea, constipation, decreased appetite, and abdominal discomfort. More serious risks may also occur, and Tirzepatide is not appropriate for everyone.
Your provider will review your medical history, current medications, treatment goals, potential risks, available alternatives, and cost considerations before determining whether Tirzepatide may be appropriate. Insurance coverage varies by medication, indication, and individual plan. Individual experiences and results vary
Phentermine is an oral prescription medication FDA-approved as a short-term adjunct to a weight-management plan that includes reduced-calorie nutrition, physical activity, and behavioral changes. It may be considered for certain adults who meet clinical eligibility criteria.
Phentermine is not appropriate for everyone. It is contraindicated in patients with certain conditions, including a history of cardiovascular disease or uncontrolled hypertension. Other contraindications, potential side effects, and medication interactions may also apply.
Your provider will review your medical history, current medications, blood pressure, treatment goals, and individual risk factors before determining whether Phentermine may be appropriate. Treatment duration and monitoring are based on clinical judgment and individual response. Results vary, and no specific amount or rate of weight loss is guaranteed. Not for long-term use.
Human Chorionic Gonadotropin, or HCG, is a prescription hormone that has been used in medicine for many years. Over time, some HCG-associated protocols have been structured in phases that include preparation, a medically supervised reduced-calorie nutrition plan, and maintenance. The duration and level of monitoring depend on the individual patient and the provider’s clinical judgment.
It is important to note that HCG is not FDA-approved for weight loss, and current evidence has not established that it increases weight loss beyond the effects of calorie restriction alone. Highly restrictive diets may carry significant health risks and should only be considered with appropriate medical supervision.
Your provider will review your health history, treatment goals, potential risks, and available alternatives before determining which weight-management approach may be appropriate for you.
Don’t see what you’re looking for? Additional prescription and nonprescription weight-management options may be available based on your health history, treatment goals, previous experiences, and current medication availability.
Schedule a consultation to discuss which options may be appropriate for you. Your provider will review the potential benefits, risks, alternatives, and costs before recommending an individualized plan.
A clinical evaluation is required. Treatment and medication availability are not guaranteed.
You do not have to determine the right option on your own. That is the purpose of meeting with a provider.
During your consultation, your provider will review your medical history, current medications, previous weight-management efforts, treatment goals, preferences, and relevant risk factors. Insurance coverage and self-pay considerations may also be discussed.
Based on this evaluation, your provider will explain which treatment options may be appropriate, along with their potential benefits, risks, alternatives, monitoring requirements, and costs. If a particular medication is not appropriate or accessible, other evidence-based approaches may be considered. A consultation does not guarantee that medication will be prescribed, and individual results vary.
Our goal is to help you make an informed decision and develop a plan that reflects your individual needs.
For a broader overview of our medical weight-management services, visit our main weight-loss page.
We believe patients should have helpful cost information when considering medical weight management. Pricing for most of our services and programs is available on our services pricing page.
Some treatment costs vary based on the medication selected, dosage, program duration, monitoring needs, and individual treatment plan. Your provider will discuss applicable costs before treatment begins so you can make an informed decision.
We accept HSA and FSA payments for eligible services. Visit our current offers page for available new-patient promotions, eligibility requirements, and restrictions.
A consultation is required to determine which treatment options, if any, may be clinically appropriate. Pricing and medication availability are subject to change.
Your first visit takes about 30 minutes. Your provider reviews your medical history, performs a basic exam, orders baseline labs when appropriate, and walks through which medications fit your situation. If you decide to start that day, you can leave with a prescription or a medication-in-hand depending on the option you select.
Most patients see initial appetite changes within the first one to two weeks on GLP-1 medications. Measurable weight loss typically starts around weeks three to four. The full effect of dose-escalated Semaglutide or Tirzepatide takes about three to four months. Patience and Compliance matters with this process.
We schedule follow-up visits every four to six weeks during active treatment to monitor progress, adjust doses, and address any side effects. This is not a fire-and-forget prescription. It is a relationship with your provider.
Chad Dance, FNP-C, MSN, MS, is the clinician leading Keystone’s medical weight-management program. He works alongside the other nurse practitioners at our Gilbert and Mesa Eastmark locations to support consistent, individualized patient care.
Chad earned master’s degrees from the University of Phoenix and Idaho State University and has more than thirteen years of combined nursing and nurse practitioner experience. Before becoming a nurse practitioner, he spent more than five years as an ICU nurse at a Level II trauma center, caring for patients with complex medical, surgical, neurological, and cardiac needs.
His critical-care background contributes to the program’s emphasis on careful evaluation, medication management, patient education, and ongoing monitoring. Depending on scheduling and location, patients may be seen by Chad or another licensed Keystone nurse practitioner.
Chad is fluent in conversational and medical Spanish. Patients may request a Spanish-language appointment when scheduling, subject to provider availability. Habla español.
Our Mesa Eastmark office at 10706 East Point Twenty-Two Boulevard serves patients across the southeast Valley. Most commonly:
From within Mesa: Eastmark, Mulberry, Mountain Ranch, Sunland Springs, Cadence, Blossom Rock, and Residence communities. Drive times are five to fifteen minutes for almost all of southeast Mesa.
From Queen Creek: under fifteen minutes from most addresses, often under ten. Queen Creek is one of our primary service markets.
From Apache Junction and Gold Canyon: about twenty minutes via Highway 60. We see a steady stream of patients from both areas, particularly for our weight loss and HRT services.
If you would prefer our Gilbert medical weight loss program instead, our Gilbert office at 3076 East Chandler Heights Road offers the same medications and the same provider model. Choose whichever drive is shorter for you.
10706 E. Point Twenty-Two Blvd, Suite a106, Mesa, AZ 85212
Located on the NW corner of E. Point Twenty-Two Boulevard, Warner Road, and S. Signal Butte Road, in the heart of the Eastmark community. Get Directions
Phone: (480) 485-9677
Pricing for many of our medical weight-management services is available on our services pricing page. Final costs vary based on the treatment selected, dosage, program duration, monitoring needs, and individualized care plan.
We accept HSA and FSA payments for eligible services. Your provider will review treatment options and associated costs before treatment begins.
Yes. Our Mesa Eastmark office is physically located in the Eastmark community at 10706 East Point Twenty-Two Boulevard, near the Banner Health Center at Eastmark. We offer the full medical weight loss program from this location, including Semaglutide, Tirzepatide, HCG, and Phentermine.
Weight loss varies by patient and depends on factors such as the specific medication and formulation, dosage, treatment duration, starting weight, medical conditions, treatment response, and lifestyle habits.
Clinical trials of FDA-approved products containing semaglutide or tirzepatide have reported average weight reduction in certain study populations. Individual outcomes varied, and clinical-trial results should not be assumed to apply to compounded formulations.
Your provider will discuss realistic expectations, monitor your progress, and adjust your treatment plan when clinically appropriate. Individual results vary, and no specific amount or rate of weight loss can be guaranteed.
Semaglutide acts on GLP-1 receptors, while Tirzepatide acts on both GIP and GLP-1 receptors. Both medications influence appetite, glucose regulation, and digestion through different mechanisms.
Clinical trials of specific FDA-approved products have reported different average weight-loss outcomes in studied populations. However, those results depend on the formulation, dosage, treatment duration, and patient population and should not be assumed to apply to compounded formulations or predict an individual patient’s results.
The appropriate option depends on your medical history, current medications, previous treatment response, potential risks, treatment goals, product availability, insurance coverage, and cost considerations. Your provider will review these factors with you before recommending a treatment plan. Individual results vary.
The timing and amount of weight loss vary by patient. Some patients may notice changes in appetite or eating patterns during the early stages of treatment, while changes in weight may develop more gradually.
Results depend on factors such as the medication and formulation used, dosage, dose-adjustment schedule, starting weight, medical conditions, treatment response, and lifestyle habits. Reaching an appropriate dose may take time, and continued progress depends on the individual treatment plan.
Your provider will monitor your response, discuss realistic expectations, and adjust treatment when clinically appropriate. Medical weight management is an ongoing process, and no specific timeline or result can be guaranteed.
Yes. Queen Creek is one of our primary service markets at our Mesa Eastmark office. Most of Queen Creek is within fifteen minutes of our Eastmark location, often under ten. Many of our weight loss patients drive from Queen Creek because we are closer than competing wellness clinics further west.
Semaglutide and Tirzepatide can cause side effects. Commonly reported effects include nausea, vomiting, diarrhea, constipation, abdominal discomfort, decreased appetite, and fatigue. Side effects may occur when treatment begins or after a dose adjustment, but their timing, duration, and severity vary by patient.
More serious risks may include pancreatitis, gallbladder problems, dehydration-related kidney injury, severe gastrointestinal reactions, low blood sugar when used with certain diabetes medications, and serious allergic reactions.
These medications are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Other warnings, contraindications, and medication interactions may apply.
This is not a complete list of potential side effects or risks. Your provider will review your medical history and current medications, screen for relevant risk factors, and discuss the specific formulation before determining whether treatment may be appropriate.
Yes. Depending on your clinical needs, non-injection options may be available. For certain eligible patients, a provider may consider Phentermine, an oral prescription medication FDA-approved as a short-term adjunct to nutrition, physical activity, and behavioral changes.
Nutrition planning, lifestyle support, and ongoing clinical monitoring may also be incorporated into a weight-management plan without injectable medication.
Phentermine is not appropriate for everyone and has important contraindications and potential side effects. Your provider will review your medical history, current medications, blood pressure, risk factors, and treatment goals before recommending any option. A consultation does not guarantee that medication will be prescribed.
Depending on the treatment and its approved indication, prescription weight-management medication may be considered for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition, such as high blood pressure, prediabetes, or sleep apnea.
BMI is only one part of determining eligibility. Your provider will also review your medical history, current medications, previous weight-management efforts, treatment goals, potential contraindications, and individual risk factors.
Medical weight management generally works best as an ongoing process that includes follow-up care and sustainable lifestyle changes. Not every patient is a candidate for every medication, and a consultation does not guarantee that treatment will be prescribed.
The ideal patient is someone who is willing to commit to follow-up visits and lifestyle adjustments. They want a provider relationship, not a vending machine for medication.
Call (480) 485-9677 or request a consultation online. Same-week appointments are typically available at our Mesa Eastmark office.
Keystone Medical Wellness, Mesa Eastmark
10706 E. Point Twenty-Two Blvd, Suite a106
Mesa, AZ 85212
(480) 485-9677
